Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval

Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the revolutionary gene-editing method. Called Casgevy, the treatment is intended to cure sickle-cell disease and a related condition, beta thalassemia. The manufacturers, Vertex Pharmaceuticals, based in Boston, and CRISPR Therapeutics, based in Switzerland, say about 2,000 patients in Britain with sickle-cell disease or…

Details

How to Skip the Turkey

We’re one week out from Thanksgiving, and you need showstopping sides (read to the very end for rapid-fire recipes) and meatless mains and dairy-free desserts, and you need them stat. So let’s not waste a moment of time. This … is Recipe Matchmaker. Replacing the Turkey “I am looking for a stand-in main dish to…

Details